IL-33 levels were found to be significantly elevated upon a cyclic stretch of cardiac fibroblasts in vitro, and the administration of IL-33 was shown to inhibit myocyte amino acid incorporation and growth thus protecting against cardiac hypertrophy (57). This evidence concerns the gene IL33 and cardiac hypertrophy.